The RCI - Regensburg Centre for Interventional Immunology (foundation public law) researches and develops new immunotherapies for the treatment of tumours, autoimmune diseases and transplant rejections. The Chair for Genetic Immunotherapy at the RCI, Prof. Dr. Hinrich Abken, is recruiting a Post-doctoral Scientist in “CAR redirected T cells”

ERC Horizon Europe 2021 funding
calls open. View the work programme
and calendar for grant competitions.

Eine Nachricht des Präsidenten der DG-GT